Washington, D.C. February 26, 2014. Today Representative Darrell Issa, Chairman of the House Committee on Oversight and Government Reform and Senator Charles Grassley, Ranking Member of the Senate Judiciary Committee issued a highly important Joint Staff Report carefully analyzing the FDA’s practice of monitoring email communications sent by whistleblowers.
The Joint Staff Report harshly criticized FDA’s practices and vindicated the allegations raised by FDA whistleblowers who exposed the illegally monitoring practices. The Joint Staff Report concluded that the FDA spied on its employees “without regard” for their “rights to communicate with Congress.” [p. 7]. The Congressional report also found that the FDA failed to “manage” their “monitoring program responsibly,” and that the FDA’s email monitoring policies “do not provide safeguards to protect whistleblowers from retaliation.” [Report pp. 7, 10].
A copy of the complete report: “Limitless Surveillance At The FDA: Protecting The Rights Of Federal Whistleblowers”
Read The Washington Post article: Lawmakers’ report: FDA monitoring of staff e-mails may have violated whistleblowing law
